Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Catalyst Grant: Health Effects of Vaping

McMaster University

$100,000.00

Impact of Cannabis Vapor Exposure on Primary Human Airway Epithelial Cell Immune Responses

FY 2020-21

Summary
Around the world there are an estimated 200 million cannabis users with the majority of these individuals using inhalation as the dominant delivery route. Canada is the first G8 country to legalize recreational cannabis use, with an estimated 20% of the population having consumed cannabis in the last year. Cannabis smoking exposes the breathing tubes in the lungs to combustion byproducts that have the potential to induce inflammation and swelling. The breathing tubes are lined with cells called "epithelial cells" and other immune cells that help fight infections. Our group has demonstrated that cannabis smoke exposure reduces the ability of some lung cells to fight infections. Cannabis vaping eliminates the combustion byproducts associated with cannabis smoking. Eliminating the cannabis byproducts may reduce the inflammation and swelling of the breathing tubes, although this remains to be determined. If demonstrated that vaping does not lead to inflammation and swelling of the breathing tubes, this delivery method could be an effective harm reduction strategy that could replace cannabis smoking. We seek to determine how cannabis vaping exposure impacts human lung epithelial cell immune defences against viruses. Our project will use human lung epithelial cells from volunteer donors. We will grow these cells in plastic dishes that mimic the human lung environment. Using these human lung models, we will examine how exposure to increasing amounts of cannabis vapor impacts the ability of the cells to survive and defend against viruses that cause lung infections in humans. Our proposed studies will form a foundation for understanding the impact of cannabis vapor exposure on lung immune function in the context of clinically relevant viral exposures, guiding responsible use of cannabis by the population, regulation by government authorities, and production practices by commercial entities.
Program
Catalyst Grant: Health Effects of Vaping
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
424067
Name
Hirota Jeremy A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Catalyst Grant : Health Effects of Vaping
Projecttitle
Impact of Cannabis Vapor Exposure on Primary Human Airway Epithelial Cell Immune Responses
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Health Effects of Vaping
Keyworddelim
Cannabis; Epithelial Cells; In Vitro; Influenza A; Lung Immunity; Transcriptomics; Vaping
Abstract
Around the world there are an estimated 200 million cannabis users with the majority of these individuals using inhalation as the dominant delivery route. Canada is the first G8 country to legalize recreational cannabis use, with an estimated 20% of the population having consumed cannabis in the last year. Cannabis smoking exposes the breathing tubes in the lungs to combustion byproducts that have the potential to induce inflammation and swelling. The breathing tubes are lined with cells called "epithelial cells" and other immune cells that help fight infections. Our group has demonstrated that cannabis smoke exposure reduces the ability of some lung cells to fight infections. Cannabis vaping eliminates the combustion byproducts associated with cannabis smoking. Eliminating the cannabis byproducts may reduce the inflammation and swelling of the breathing tubes, although this remains to be determined. If demonstrated that vaping does not lead to inflammation and swelling of the breathing tubes, this delivery method could be an effective harm reduction strategy that could replace cannabis smoking. We seek to determine how cannabis vaping exposure impacts human lung epithelial cell immune defences against viruses. Our project will use human lung epithelial cells from volunteer donors. We will grow these cells in plastic dishes that mimic the human lung environment. Using these human lung models, we will examine how exposure to increasing amounts of cannabis vapor impacts the ability of the cells to survive and defend against viruses that cause lung infections in humans. Our proposed studies will form a foundation for understanding the impact of cannabis vapor exposure on lung immune function in the context of clinically relevant viral exposures, guiding responsible use of cannabis by the population, regulation by government authorities, and production practices by commercial entities.
Competitiondate
202006
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hirota, Jeremy A; MacKillop, James
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Circ &Respiratory Hlth~ $100,000~ $0~
McMaster University - $100,000 Grant (2020-21) | Canada Spends